Psyence Group Inc
CNSX:PSYG
Psyence Group Inc
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-01-27. The firm builds and operates commercial psilocybin cultivation and production facilities. The company offers natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences. The Company’s natural psychedelics are cultivated in Lesotho. The company focuses on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin. The company operates across Toronto, Canada; Washington District of Columbia (DC), United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.
Psyence Group, Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-01-27. The firm builds and operates commercial psilocybin cultivation and production facilities. The company offers natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences. The Company’s natural psychedelics are cultivated in Lesotho. The company focuses on the scientific research and development of psilocybin medical products for research institutions, clinics and regulatory-compliant psilocybin. The company operates across Toronto, Canada; Washington District of Columbia (DC), United States of America; Cape Town, South Africa; Kolojane, Kingdom of Lesotho; Kingston, Jamaica; London United Kingdom; Sydney, Australia and Sao Paulo, Brazil.
